bullish
Valuation of Celltrion + Celltrion Healthcare Is Not as Expensive as Samsung Biologics
274 Views13 Jul 2017 11:26
Celltrion Healthcare (091990 KS) (CH) is raising US$701 - 884m in its upcoming IPO. Proceeds raised will be used to fund general working capital,...
SUMMARY
(Sign Up to Access)Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 9-minute read)
Discussions
(Paid Plans Only)
Zhen Zhou, Toh
APAC IPOs & Placements
- Celltrion's KOSPI Move - Seo Jung-Jin, Temasek & Price Predictions28 Sep 2017
- Celltrion Has Potential Manufacturing Headaches07 Sep 2017
- More Discussions on Impacts of Celltrion's KOSPI200 Inclusion23 Aug 2017
- Valuation of Celltrion + Celltrion Healthcare Is Not as Expensive as Samsung Biologics13 Jul 2017
- Celltrion Healthcare IPO Part 4 - Valuation & Pricing Debate12 Jul 2017
- Celltrion Healthcare IPO Part 3 - What Local Institutions Seem to Have in Mind03 Jul 2017
x